Australia
Accelerating its international development, the APRIL Group establishes an entity in Germany
LYON, France and PARIS, Nov. 17, 2022 /PRNewswire/ -- The APRIL Group, France's leading wholesale insurance broker, is enjoying strong growthacross multiple marketsand now accelerating its international development by setting up APRIL International GmbH. This new entity will help APRIL provide ev...
2022-11-18 09:30
3840
Island to present at World Antiviral Congress 2022
MELBOURNE, Australia, Nov. 15, 2022 /PRNewswire/ -- Australian mid-clinical stage antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA) is pleased to advise that CEO and Managing Director, DrDavid Foster will present at the World Antiviral Congress 2022 inSan Diego, USA which ...
2022-11-15 21:00
3378
ExpressVPN's protections examined in two new independent audits, by KPMG and Cure53
TORTOLA, British Virgin Islands, Nov. 10, 2022 /PRNewswire/ -- Leading consumer privacy and security company ExpressVPN today publishes two new audits by KPMG and Cure53. The audits underline ExpressVPN's commitment to transparency and delivering to customers privacy and security that they can tr...
2022-11-10 16:00
2297
Enterprise Loyalty Cloud, Antavo, closes €10M Series A giving rise to next-gen omnichannel loyalty programs
The funding will enable the expansion of Antavo's global presence and further
development of the best-in-class, no-code loyalty technology for enterprises
LONDON, Nov. 9, 2022 /PRNewswire/ -- Enterprise Loyalty Cloud platform, Antavo
2022-11-09 16:00
2579
Symbio launches Carrier Infrastructure as a Service offering for wholesale customers
SYDNEY, Nov. 7, 2022 /PRNewswire/ -- Industry-leading communications software provider Symbio Holdings (ASX: SYM), today announced the launch of Carrier Infrastructure as a Service (CIaaS) – a unified carrier-grade product suite designed to simplify the wholesale customer experience. Symbio'...
2022-11-08 09:30
2609
Alterity Therapeutics Announces Presentation of Data from the bioMUSE Natural History Study at the American Autonomic Society Annual Meeting
MELBOURNE, Australia and SAN FRANCISCO, Nov. 7, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation fro...
2022-11-07 23:25
3448
Certa Therapeutics' investigational drug FT011 delivers breakthrough results as a potential novel treatment for serious inflammatory and fibrotic diseases
* Research presented today by University of Michigan Medical School highlights FT011's ground-breaking treatment potential from human expression profiles in chronic kidney disease study supported by animal model data * The research demonstrated that treatment with FT011 results in a remarkable...
2022-11-04 20:00
3213
Microsoft overtakes Amazon in Interbrand's 2022 Best Global Brands Report
- Apple retains top spot as the Top 100 Brands ranking exceeds more than $3 trillion for the first time - a 16% increase since 2021 - Airbnb (#54), Red Bull (#64) and Xiaomi (#84) are new entrants for 2022 - Microsoft (#2), Tesla (#12) and Chanel (#22) see the greatest YoY growth - Nike (#10) en...
2022-11-04 02:24
3534
LiveHire Announced as a Member on Newly Launched AMS Verified
MIAMI, Nov. 3, 2022 /PRNewswire/ -- LiveHire, the globally-leading direct sourcing and total talent platform, announced its membership on the newly launched AMS Verified platform. LiveHire and AMS launched a strategic alliance in 2021 to expand their joint offering to enterprises inNorth America....
2022-11-03 23:03
3311
The future you desire. The life of your dreams. See it, feel it, believe it. Get ready to receive it with LIFEBOARD VR.
SYDNEY, Oct. 26, 2022 /PRNewswire/ -- The first of its kind and totally unique – Lifeboard VR is a ground-breaking new manifestation platform to help users bring to reality their dreams and goals. It's time to enter a fully immersive virtual reality world where you can customize your vision boar...
2022-10-26 21:01
2832
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting
MELBOURNE, Australia and SAN FRANCISCO , Oct. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation f...
2022-10-26 19:25
3262
Acting coach of EUPHORIA star Jacob Elordi and other stars launches new book, spills secrets on how to land the role of a lifetime; and working with De Niro, Pacino and Spielberg
SYDNEY, Oct. 25, 2022 /PRNewswire/ -- World-renowned Australian acting coach Les Chantery has written his first book,Life in a Mid-Shot, a bold new approach to screen auditions proven to land actors the part of their dreams. A conversation on set with Al Pacino in 2007 prompted an ah-ha moment fo...
2022-10-26 00:00
2860
BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing
BRISBANE, Australia, Oct. 20, 2022 /PRNewswire/ -- BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing inAustralia, paving the way for the global life sciences company to provide clinical sequencing ...
2022-10-20 15:27
2214
Symbio extends its Asia expansion into Taiwan
SYDNEY, Oct. 19, 2022 /PRNewswire/ -- Symbio Holdings Limited (ASX: SYM), a leading voice communications software provider, today marked the next milestone in itsAsia-Pacific expansion strategy, announcing it will open service availability inTaiwan in 2023. With the Taiwanese Data Centre marke...
2022-10-19 15:35
2420
PIVALATE ACHIEVES POSITIVE PHASE 2 DATA IN BRAIN METS TRIAL
* F-18 Pivalate PET shows high uptake regardless of origin of primary tumour * F-18 Pivalate can be used to monitor cerebral metastases * Patients without previous external beam radiation show higher tumour uptake, while those previously treated show a trend towards lower uptake MELBOURNE, A...
2022-10-19 11:12
1922
Australian parcel theft rockets to an all-time high with the second largest rise than any other country globally
* First global report on parcel theft * Over a third of Australians affected by parcel theft or loss in lifetime * One in ten people globally are now reluctant to shop online because of fear of theft * Australia second highest on global list of increasing parcel problems * Sharpest rise a...
2022-10-17 05:00
2177
Top 100 Tech Retail Start-Up, HIVERY, named Exporter of the Year 2022
SYDNEY, Oct. 14, 2022 /PRNewswire/ -- HIVERY, a leader in innovative AI-driven
retail assortment strategy simulation & optimization solutions, was announced
as a winner of the2022 Premier's NSW Exporter of the Year
2022-10-14 14:54
2070
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in Australia for the Treatment of Individuals with Multiple System Atrophy
Australia now open for study of rare, rapidly progressive Parkinsonian Disorder MELBOURNE, Australia and SAN FRANCISCO, Oct. 13, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying t...
2022-10-13 22:25
2379
Actinogen Medical Limited (ACW) announces large Xanamem® therapeutic effect in early-stage Alzheimer's Disease (AD) patients
Clinical Dementia Rating Scale - Sum of Boxes effect of 0.6 to 0.8 points observed in patients with elevated pTau biomarker with once daily, 10 mg, oral therapy SYDNEY, Oct. 10, 2022 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) today announces positive Phase 2a clinical data from its Alz...
2022-10-10 20:00
2505
First patient treated in Clarity's therapeutic prostate cancer trial
Highlights * Clarity Pharmaceuticals recruits and treats its first patient in the therapeutic phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT04868604)[1] investigating Targeted Copper Theranostics (TCTs) in patients with metastatic castrate-resistant prostate cancer (mCRPC) ...
2022-10-07 21:06
2615
Week's Top Stories
Most Reposted
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 278 media titles]
2026-09-28 23:04
Malaysia Calls for Shift from Halal-Certified to Halal-Competitive as ASEAN Targets USD5 Trillion Global Halal Economy
[Picked up by 277 media titles]
2026-09-25 14:45
Nuix Recognised as a RiskTech100® 2027 Disruptor by Chartis Research
[Picked up by 274 media titles]
2026-09-25 08:30Allianz Partners unveils next-generation travel insurance platform to help partners navigate changing landscape
[Picked up by 269 media titles]
2026-09-28 07:30
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
14156
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
12857
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
11952
